Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CyberArk Software | CYBR | Nov 18, 2024 | 305.74 | +0.15 |
Cybin | CYBN | Nov 18, 2024 | 10.60 | -8.62 |
Cyclacel Pharmaceuticals | CYCC | Nov 18, 2024 | 0.36 | -3.37 |
Cyclacel Pharmaceuticals Pref | CYCCP | Nov 18, 2024 | 6.61 | 0.00 |
Cyclerion Therapeutics | CYCN | Nov 18, 2024 | 2.09 | -18.99 |
Cyclo Therapeutics | CYTH | Nov 18, 2024 | 0.72 | +3.00 |
Cyngn | CYN | Nov 18, 2024 | 5.76 | -2.21 |
Cytek Biosciences | CTKB | Nov 18, 2024 | 6.03 | +1.34 |
Cytokinetics | CYTK | Nov 18, 2024 | 51.94 | +3.42 |
Cytomed Therapeutics | GDTC | Nov 18, 2024 | 1.94 | -10.78 |
CytomX Therapeutics | CTMX | Nov 18, 2024 | 0.86 | -5.14 |
Cytosorbents | CTSO | Nov 18, 2024 | 0.93 | +3.91 |
D-MARKET Electronic Services & Trading ADR | HEPS | Nov 18, 2024 | 2.89 | -1.03 |
D-Wave Quantum | QBTS | Nov 18, 2024 | 1.44 | -12.20 |
D.R. Horton | DHI | Nov 18, 2024 | 161.45 | -0.10 |
Dada Nexus ADR | DADA | Nov 18, 2024 | 1.44 | +4.35 |
Daily Journal | DJCO | Nov 18, 2024 | 554.50 | +1.00 |
Dakota Gold | DC | Nov 18, 2024 | 2.17 | +0.46 |
Daktronics | DAKT | Nov 18, 2024 | 14.80 | +2.00 |
DallasNews A | DALN | Nov 18, 2024 | 5.04 | -2.33 |
Dana | DAN | Nov 18, 2024 | 7.99 | -1.72 |
Danaher | DHR | Nov 18, 2024 | 230.06 | -0.19 |
Danaos | DAC | Nov 18, 2024 | 86.39 | +0.73 |
Danimer Scientific | DNMR | Nov 18, 2024 | 8.04 | -6.94 |
DAQO New Energy ADR | DQ | Nov 18, 2024 | 19.04 | -1.09 |
Darden Restaurants | DRI | Nov 18, 2024 | 164.45 | -1.40 |
Daré Bioscience | DARE | Nov 18, 2024 | 3.20 | -0.31 |
DarioHealth | DRIO | Nov 18, 2024 | 0.80 | +3.76 |
Darling Ingredients | DAR | Nov 18, 2024 | 42.49 | -1.30 |
Data I/O | DAIO | Nov 18, 2024 | 2.57 | -0.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.